論文

査読有り 筆頭著者 本文へのリンクあり
2017年12月15日

Design, synthesis, and evaluation of A-ring-modified lamellarin N analogues as noncovalent inhibitors of the EGFR T790M/L858R mutant

Bioorganic and Medicinal Chemistry
  • Tsutomu Fukuda
  • ,
  • Teppei Umeki
  • ,
  • Keiji Tokushima
  • ,
  • Gao Xiang
  • ,
  • Yuki Yoshida
  • ,
  • Fumito Ishibashi
  • ,
  • Yusuke Oku
  • ,
  • Naoyuki Nishiya
  • ,
  • Yoshimasa Uehara
  • ,
  • Masatomo Iwao

25
24
開始ページ
6563
終了ページ
6580
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.bmc.2017.10.030
出版者・発行元
Elsevier Ltd

A series of A-ring-modified lamellarin N analogues were designed, synthesized, and evaluated as potential noncovalent inhibitors of the EGFR T790M/L858R mutant, a causal factor in the drug-resistant non-small cell lung cancer. Several water-soluble ammonium- or guanidinium-tethered analogues exhibited good kinase inhibitory activities. The most promising analogue, 14f, displayed an excellent inhibitory profile against the T790M/L858R mutant [IC50 (WT) = 31.8 nM
IC50 (T790M/L858R) = 8.9 nM]. The effects of A-ring-substituents on activity were rationalized by docking studies.

リンク情報
DOI
https://doi.org/10.1016/j.bmc.2017.10.030
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/29133033
URL
http://hdl.handle.net/10069/38936 本文へのリンクあり
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85033567176&origin=inward
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85033567176&origin=inward
ID情報
  • DOI : 10.1016/j.bmc.2017.10.030
  • ISSN : 1464-3391
  • ISSN : 0968-0896
  • eISSN : 1464-3391
  • ORCIDのPut Code : 38529013
  • PubMed ID : 29133033
  • SCOPUS ID : 85033567176

エクスポート
BibTeX RIS